Experts urge further improvements in COVID-19 testing to increase speed and availability

NewsGuard 100/100 Score

In an important, comprehensive, and timely review, an expert team from the University of California Berkeley details the methodologies used in nucleic acid-based tests for detecting the presence of SARS-CoV-2, the virus that causes COVID-19. They show that these tests vary widely in applicability to mass screening and urge further improvements in testing technologies to increase speed and availability.

Testing for the presence of the SARS-CoV-2 virus has been extensively discussed during the COVID-19 pandemic. The most sensitive tests measure the presence of the virus' genetic material, RNA, in a patient's sample, suggesting an ongoing infection. A huge effort is needed to scale up COVID-19 testing to a level required to ensure public safety. Many tests take several hours to complete and require extensive human labor as well as materials and equipment that are not universally available.

There is a pressing need for alternatives, and the research community worldwide has provided a large number of them in journal articles and preprints (papers that have not yet been peer reviewed). The Berkeley scientists have assessed these approaches and show that some tests take minutes, some take hours, many are done in different ways, and they vary in cost and potential for mass use. The authors are "hopeful that the explosion of creative and multifaceted approaches to COVID-19 nucleic-acid testing will continue to seed solutions as society addresses the COVID-19 pandemic."

Source:
Journal reference:

Esbin, M.N., et al. (2020) Overcoming the bottleneck to widespread testing: A rapid review of nucleic acid testing approaches for COVID-19 detection. RNA. doi.org/10.1261/rna.076232.120.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Paxlovid enhances treatment options for COVID-19 patients